5Francis H, Solomon B. The current status of targeted therapy for non - small cell lung cancer [ J ]. Intern Med J, 2010,40 ( 9 ) : 611 - 618.
6Liu H, Wang Z, Li Y, et al. Simvastatin prevents proliferation and bone metastases of lung adenocarcinoma in vitro and in vivo [ J ]. Neoplasma,2013,60 ( 3 ) :240 - 246.
7Yang G, Yao Y,Zhou J,et al. Effects of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor,in EGFR - mutated non - small cell lung cancer [ J ]. Oncol Rep,2012,27 (6) :2066 - 2072.
8Gao J,Zhao Y, Lv Y,et al. Mirk/DyrklB mediates G0/GI to S phase cell cycle progression and cell survival involving MAPK/ ERK signaling in human cancer cells[ J]. Cancer Cell Int,2013, 13(1):2.
9Sun CK, Man K, Ng KT, et al. Proline - rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatoeellular carcinoma cells through c - Src/ERK activation [ J ]. Carcinogene- sis,2008,29( 11 ) :2096 -2105.
10Ung CY,Li H, Ma XH,et al. Simulation of the regulation of EGFR endoeytosis and EGFR - ERK signaling by endophilin - mediated RhoA - EGFR crosstalk [ J ]. FEBS Lett, 2008,582 ( 15 ) : 2283 - 2290.
